| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/ICE.2016.145 |
| P698 | PubMed publication ID | 27406609 |
| P50 | author | Hsiu-Yin Chiang | Q41555916 |
| Eli Perencevich | Q56876774 | ||
| Amy Blevins | Q57034005 | ||
| Matthew Samore | Q63144416 | ||
| Marin Schweizer | Q63373942 | ||
| Margaret L Chorazy | Q117248500 | ||
| P2093 | author name string | Scott D Nelson | |
| Karim Khader | |||
| Melissa A Ward | |||
| Richard E Nelson | |||
| P2860 | cites work | Long-term trends in Medicare payments in the last year of life | Q33725839 |
| Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs | Q34175419 | ||
| Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration | Q34257801 | ||
| Out-of-pocket spending in the last five years of life | Q34297585 | ||
| Cost of illness studies: what is good about them? | Q35389768 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Health care costs for patients with cancer at the end of life | Q36406099 | ||
| Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009 | Q36908277 | ||
| Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. | Q37072944 | ||
| Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization | Q37302581 | ||
| Current control and treatment of multidrug-resistant Acinetobacter baumannii infections | Q37330689 | ||
| Estimating the cost of health care-associated infections: mind your p's and q's. | Q37697184 | ||
| Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. | Q38133761 | ||
| Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review | Q38226435 | ||
| The economic impact of Clostridium difficile infection: a systematic review | Q38409139 | ||
| Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital | Q39525380 | ||
| Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system | Q39922949 | ||
| Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence. | Q41138033 | ||
| The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on post-discharge healthcare costs and utilization | Q41348984 | ||
| Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality | Q41560166 | ||
| Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned | Q44045605 | ||
| Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship | Q44975350 | ||
| Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences | Q45048702 | ||
| Cost-of-illness studies: fact or fiction? | Q45939053 | ||
| "Never events": not every hospital-acquired infection is preventable | Q47632919 | ||
| Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble. | Q50940139 | ||
| Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. | Q53883952 | ||
| Multi-resistant Acinetobacter baumannii on a burns unit--clinical risk factors and prognosis. | Q53968750 | ||
| Attributable mortality of nosocomial Acinetobacter bacteremia | Q79839567 | ||
| Cost-of-illness studies: a guide to critical evaluation | Q84173560 | ||
| Cost-of-illness analyses for policy making: a cautionary tale of use and misuse | Q84642715 | ||
| P433 | issue | 10 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 1212-1218 | |
| P577 | publication date | 2016-07-13 | |
| P1433 | published in | Infection Control and Hospital Epidemiology | Q6029185 |
| P1476 | title | Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections | |
| P478 | volume | 37 |
| Q64283724 | A 5-year surveillance on antimicrobial resistance of isolates at a level-I trauma centre of India |
| Q33732524 | Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections |
| Q99711657 | Antimicrobial profile of Acinetobacter baumannii at a tertiary hospital in Honduras: a cross-sectional analysis |
| Q100385051 | Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans' Affairs (VA) medical centers |
| Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
| Q40480076 | Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. |
Search more.